share_log

424B5: Prospectus

424B5: Prospectus

424B5：募資說明書
美股SEC公告 ·  09/03 09:21
Moomoo AI 已提取核心訊息
Cingulate, a company listed on the Nasdaq Capital Market under the symbol 'CING', has filed a prospectus supplement on September 3, 2024, to update its previous offering terms. The supplement amends the prior prospectus dated January 13, 2023, and its subsequent supplements, to increase the amount of common stock the company is eligible to sell. Under the revised terms, Cingulate may now offer and sell shares with an aggregate offering price of up to $3,870,000 through H.C. Wainwright & Co., LLC, acting as the sales agent. This new limit is in addition to the $11,323,947.19 worth of common stock already sold under the previous prospectus. The public float of Cingulate's common stock was valued at over $40 million as of September 3, 2024, based on the closing price of $17.69 per share on August 16, 2024. The last reported sale price of Cingulate's common stock was $7.89 per share on August 30, 2024.
Cingulate, a company listed on the Nasdaq Capital Market under the symbol 'CING', has filed a prospectus supplement on September 3, 2024, to update its previous offering terms. The supplement amends the prior prospectus dated January 13, 2023, and its subsequent supplements, to increase the amount of common stock the company is eligible to sell. Under the revised terms, Cingulate may now offer and sell shares with an aggregate offering price of up to $3,870,000 through H.C. Wainwright & Co., LLC, acting as the sales agent. This new limit is in addition to the $11,323,947.19 worth of common stock already sold under the previous prospectus. The public float of Cingulate's common stock was valued at over $40 million as of September 3, 2024, based on the closing price of $17.69 per share on August 16, 2024. The last reported sale price of Cingulate's common stock was $7.89 per share on August 30, 2024.
Cingulate，一家在納斯達克資本市場上市的公司，股票代碼爲'CING'，於2024年9月3日提交了一份招股補充說明書，以更新先前的發行條款。該補充說明書修訂了先前於2023年1月13日的招股說明書及後續補充內容，以增加公司有資格出售的普通股數量。根據修訂後的條款，Cingulate現在可以通過H.C. Wainwright & Co., LLC作爲銷售代理，提供並銷售總計高達$3,870,000的股份。這一新限額是之前招股說明書下已出售的總值爲$11,323,947.19的普通股額外的。Cingulate的普通股公開發行股數截至2024年9月3日根據2024年8月16日每股$17.69的收盤價估值超過4000萬美元。Cingulate的普通股最後報告的銷售價格爲2024年8月30日每股$7.89。
Cingulate，一家在納斯達克資本市場上市的公司，股票代碼爲'CING'，於2024年9月3日提交了一份招股補充說明書，以更新先前的發行條款。該補充說明書修訂了先前於2023年1月13日的招股說明書及後續補充內容，以增加公司有資格出售的普通股數量。根據修訂後的條款，Cingulate現在可以通過H.C. Wainwright & Co., LLC作爲銷售代理，提供並銷售總計高達$3,870,000的股份。這一新限額是之前招股說明書下已出售的總值爲$11,323,947.19的普通股額外的。Cingulate的普通股公開發行股數截至2024年9月3日根據2024年8月16日每股$17.69的收盤價估值超過4000萬美元。Cingulate的普通股最後報告的銷售價格爲2024年8月30日每股$7.89。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息